Cited by 1,657Cerebrovascular and genetic disordersNeurological Disease Mechanisms and TreatmentsIntracerebral and Subarachnoid Hemorrhage Research

The DOI matches its Crossref record; 163 of the 168 references it cites were found in a registry or an index; 2 of the 208 sources its claims cite were checked for support.

Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging

Open access
Wardlaw, Joanna M, Smith, Colin, Dichgans, Martin·2013·The Lancet Neurology

Abstract

The term cerebral small vessel disease (SVD) describes a range of neuroimaging, pathological, and associated clinical features. Clinical features range from none, to discrete focal neurological symptoms (eg, stroke), to insidious global neurological dysfunction and dementia. The burden on public health is substantial. The pathogenesis of SVD is largely unknown. Although the pathological processes leading to the arteriolar disease are associated with vascular risk factors and are believed to result from an intrinsic cerebral arteriolar occlusive disease, little is known about how these processes result in brain disease, how SVD lesions contribute to neurological or cognitive symptoms, and the association with risk factors. Pathology often shows end-stage disease, which makes identification of the earliest stages difficult. Neuroimaging provides considerable insights; although the small vessels are not easily seen themselves, the effects of their malfunction on the brain can be tracked with detailed brain imaging. We discuss potential mechanisms, detectable with neuroimaging, that might better fit the available evidence and provide testable hypotheses for future study.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(13)70060-7

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

118 Not checked yet · 19 Own interpretation · 16 No basis given · 3 Own result · 1 Own method · accuracy not yet measured

Verify all 206 references — free account

Show all 57 claims

  • It may state two separate claims as one. 92
  • Probably not a substantial claim. 15
100 of 100
  • The authors state this as an assumption.

    The core mechanism underlying SVD-related brain injury is ischaemia acting through arteriolar narrowing or occlusion, whether structural or functional.

    “The core mechanism underlying SVD-related brain injury is usually assumed to be ischaemia, acting through arteriolar narrowing or occlusion either structural or functional (e.g. vasospasm, impaired autoregulation, or hypotension).”
  • The paper relies on this without support.

    Features of SVD develop over many years before they become clinically evident.

    “Features of SVD probably develop over many years before becoming clinically evident.”
  • The paper relies on this without support.

    Perivascular oedema is toxic to neurons, glia and astrocytes.

    “In earlier stages, the perivascular oedema, which is toxic to neurons, glia, astrocytes, in fact all”
  • The authors state this as an assumption.

    Subacute lesions observed at post mortem, on the basis of size and absence of significant relevant clinical dysfunction in life, are asymptomatic lacunes.

    “Rarely, subacute lesions are observed (Supplemental Figure 3) which, on the basis of size and in the absence of any significant relevant clinical dysfunction in life, are assumed to be asymptomatic lacunes (Supplemental Figure 3a).”
  • The paper relies on this without support.

    Having a few lacunes may have similar impact in terms of cognition or stroke or dementia risk as having some WMH.

    “having a few lacunes may have similar impact in terms of cognition or stroke or dementia risk as do having some WMH.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 168 references

Research works printed but not linked: 3

  1. Valdes-Hernandez, 2012, Does the differential distribution of acute lacunar infarcts and white matter lesions in the brain explain why lacunar infarcts but not white matter lesions present with acute symptoms?, Cerebrovasc Dis, 33, 69
  2. Del Bene, 2012, Do risk factors for lacunar ischaemic stroke vary with the location or appearance of the lacunar infarct?, Cerebrovasc Dis, 33, 21
  3. Benavente, 2012, The Secondary Prevention of Small Subcortical Strokes (SPS3) study: results of the antiplatelet trial, Cerebrovasc Dis, 33, 79

Cited by

Sorted by citations

Items 101–108 of 108

Metadata

Authors
Wardlaw, J. M., Smith, C., & Dichgans, M.
Affiliations
  • Western General Hospital (GB)
  • University of Edinburgh (GB)
  • German Center for Neurodegenerative Diseases (DE)
Corresponding author
Wardlaw, Joanna M
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2013-05
Volume
12
Issue
5
Pages
483-497
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2140621953
Cited by
1,657
References
168
Citations by year
2026: 120 · 2025: 116 · 2024: 124 · 2023: 128 · 2022: 171 · 2021: 166 · 2020: 162 · 2019: 165 · 2018: 144 · 2017: 121 · 2016: 88 · 2015: 72 · 2014: 63 · 2013: 13
FWCI
10.26
Type
journal article
Language
en
Open access
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • DZNE Pub (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders
  • Wellcome Trust (088134)
  • Medical Research Council (MR/K026992/1, MR/J006971/1)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords
cerebral small vessel disease, pathogenesis, vascular risk factors, neuroimaging biomarkers, dementia, stroke, cognitive impairment
MeSH terms
Brain, Humans, Dementia, Vascular, Cerebral Small Vessel Diseases, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review